drug

nalmefene

1 story · latest Oct 9, 2026

Follow nalmefene. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved May 2023 · NDA217470, NDA218590
Brands: Opvee, Zurnai, Zurnai (autoinjector)

Relationships

Developed by Indivior Pharmaceuticals, Inc.

Also known as

nalmefene hydrochloride

Timeline

Hepion Pharmaceuticals acquires Gravitas Life Sciences, installs new CEO

Oct 9M&AHepion Pharmaceuticals, Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.